Related Experiment Video

Updated: Sep 6, 2025

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.3K

Omicron sub-variants: is the world going to witness another wave?

Amit Aggarwal1, Ashutosh Nirola2, Ravinder Singh1

  • 1Department of Oral Medicine and Radiology, MM College of Dental Sciences and Research, MM (Deemed to be University), Mullana, India.

Roczniki Panstwowego Zakladu Higieny
|June 24, 2022
PubMed

Insights

Omicron sub-variants (BA.1, BA.2) of SARS-CoV-2 show increased transmissibility and reinfection risk. Booster doses and new nasal vaccines are crucial for public health policy and preventing further spread.

Area of Science:

  • Virology
  • Public Health
  • Immunology

Background:

  • The SARS-CoV-2 Omicron variant is rapidly evolving into new sub-variants like BA.1 and BA.2.
  • These sub-variants exhibit increased transmissibility, reduced vaccine effectiveness, and a higher risk of reinfection.
  • Global surges in infections necessitate a deeper understanding of Omicron's evolution.

Purpose of the Study:

  • To review current research on newly detected Omicron sub-variants, primarily from pre-print studies.
  • To emphasize the importance of booster vaccine doses in combating Omicron.
  • To highlight emerging research on nasal vaccine formulations against new variants.

Main Methods:

  • Literature review of pre-print research on Omicron sub-variants.
  • Analysis of data on transmissibility, vaccine effectiveness, and reinfection rates.
  • Examination of studies on booster vaccine efficacy and novel nasal vaccine development.

Main Results:

  • Omicron sub-variants demonstrate enhanced characteristics compared to earlier strains.
  • Booster doses are vital for restoring and enhancing protection against Omicron.
  • New nasal vaccine formulations show potential efficacy against current and emerging variants.

Conclusions:

  • Understanding Omicron sub-variants is critical for effective public health strategies.
  • Booster vaccinations are essential to mitigate the impact of Omicron.
  • Novel vaccine approaches, including nasal vaccines, offer promising avenues for future control.
Keywords:
Omicrongenomesub-variantstransmissionvaccine

More Related Videos

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples09:26

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples

Published on: June 30, 2023

1.2K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.4K

Related Concept Videos

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.8K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.8K
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
103
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
110
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.8K
Types of Impact01:30

Types of Impact

Impacts can be classified in various forms, primarily under two subgroups: central impact and oblique impact. A central impact occurs when two objects collide head-on, possessing opposite velocities aligned along the line of impact. Conversely, an oblique impact occurs when two objects collide at an angle, resulting in a modification of both direction and velocity.
The coefficient of restitution is a metric for understanding the dynamics of impacts. It quantifies the ratio of relative velocity...
648